FFCP PHASE1:Mm9::chr13:51933176..51933183,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr13:51933176..51933183,+|id=chr13:51933176..51933183,+|ontology_enrichment_celltype=CL:0000838!3.37e-18!12;CL:0000542!8.78e-17!13;CL:0000051!8.78e-17!13;CL:0000084!4.74e-14!11;CL:0000827!4.74e-14!11;CL:0000738!8.89e-13!17;CL:0002087!8.89e-13!17;CL:0000624!1.23e-12!8;CL:0000791!2.91e-11!9;CL:0000789!2.91e-11!9;CL:0002420!2.91e-11!9;CL:0002419!2.91e-11!9;CL:0000790!2.91e-11!9;CL:0000893!8.96e-10!6;CL:0002489!8.96e-10!6;CL:0000898!8.96e-10!6;CL:0000809!8.96e-10!6;CL:0000810!8.96e-10!6;CL:0000895!8.96e-10!6;CL:0000808!8.96e-10!6;CL:0000894!8.96e-10!6;CL:0000806!8.96e-10!6;CL:0000807!8.96e-10!6;CL:0000805!8.96e-10!6;CL:0002425!8.96e-10!6;CL:0002436!8.96e-10!6;CL:0002427!8.96e-10!6;CL:0002428!8.96e-10!6;CL:0002429!8.96e-10!6;CL:0002433!8.96e-10!6;CL:0002431!8.96e-10!6;CL:0002432!8.96e-10!6;CL:0002031!1.36e-08!25;CL:0000815!1.14e-07!1;CL:0000792!1.14e-07!1;CL:0000945!2.37e-07!1;CL:0000236!2.37e-07!1;CL:0000826!2.37e-07!1;CL:0000355!4.50e-07!9|ontology_enrichment_celltype_v019_2=CL:0000355,1.10e-08,9|ontology_enrichment_disease=DOID:0060100!4.00e-20!3;DOID:4045!4.00e-20!3;DOID:0050686!2.32e-10!6|ontology_enrichment_disease_v019_2=DOID:0060100,6.68e-24,3;DOID:4045,6.68e-24,3;DOID:0050686,1.61e-12,6|ontology_enrichment_uberon=UBERON:0001134!4.50e-07!9;UBERON:0002036!4.50e-07!9;UBERON:0002385!4.50e-07!9;UBERON:0000486!4.50e-07!9;UBERON:0001015!4.50e-07!9;UBERON:0004290!4.50e-07!9;UBERON:0003082!4.50e-07!9|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.10e-08,9;UBERON:0002036,1.10e-08,9;UBERON:0002385,1.10e-08,9;UBERON:0000486,1.10e-08,9;UBERON:0007503,1.10e-08,9;UBERON:0001015,1.10e-08,9;UBERON:0002329,1.10e-08,9;UBERON:0003082,1.10e-08,9;UBERON:0003059,1.10e-08,9;UBERON:0007282,1.10e-08,9;UBERON:0004290,1.10e-08,9;UBERON:0009618,1.10e-08,9;UBERON:0000383,6.49e-08,10;UBERON:0007524,2.79e-07,11;UBERON:0003077,2.79e-07,11;UBERON:0007285,2.79e-07,11|phase1_expression=0,0,0,0,0,0,0,0.516493293766305,0.140788722151667,0,0,0,0.171200729931206,0.262261207256992,0,0,0,0,0,0,0,0,0.261199789138935,0,0,0,0,0.215471232685889,0,0,0,0,0,0,0,0,0,3.34825304589526,0.7813353445238,4.18818995179039,12.9410927366823,3.41522742479223,4.85510353031154,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162886959353576,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr13:51933176..51933183,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr13:51933176..51933183,+ | |||
|description=CAGE_peak_at_chr13:51933176..51933183,+ | |||
|id=chr13:51933176..51933183,+ | |||
|ontology_enrichment_celltype=CL:0000838!3.37e-18!12;CL:0000542!8.78e-17!13;CL:0000051!8.78e-17!13;CL:0000084!4.74e-14!11;CL:0000827!4.74e-14!11;CL:0000738!8.89e-13!17;CL:0002087!8.89e-13!17;CL:0000624!1.23e-12!8;CL:0000791!2.91e-11!9;CL:0000789!2.91e-11!9;CL:0002420!2.91e-11!9;CL:0002419!2.91e-11!9;CL:0000790!2.91e-11!9;CL:0000893!8.96e-10!6;CL:0002489!8.96e-10!6;CL:0000898!8.96e-10!6;CL:0000809!8.96e-10!6;CL:0000810!8.96e-10!6;CL:0000895!8.96e-10!6;CL:0000808!8.96e-10!6;CL:0000894!8.96e-10!6;CL:0000806!8.96e-10!6;CL:0000807!8.96e-10!6;CL:0000805!8.96e-10!6;CL:0002425!8.96e-10!6;CL:0002436!8.96e-10!6;CL:0002427!8.96e-10!6;CL:0002428!8.96e-10!6;CL:0002429!8.96e-10!6;CL:0002433!8.96e-10!6;CL:0002431!8.96e-10!6;CL:0002432!8.96e-10!6;CL:0002031!1.36e-08!25;CL:0000815!1.14e-07!1;CL:0000792!1.14e-07!1;CL:0000945!2.37e-07!1;CL:0000236!2.37e-07!1;CL:0000826!2.37e-07!1;CL:0000355!4.50e-07!9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,1.10e-08,9 | |||
|ontology_enrichment_disease=DOID:0060100!4.00e-20!3;DOID:4045!4.00e-20!3;DOID:0050686!2.32e-10!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,6.68e-24,3;DOID:4045,6.68e-24,3;DOID:0050686,1.61e-12,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!4.50e-07!9;UBERON:0002036!4.50e-07!9;UBERON:0002385!4.50e-07!9;UBERON:0000486!4.50e-07!9;UBERON:0001015!4.50e-07!9;UBERON:0004290!4.50e-07!9;UBERON:0003082!4.50e-07!9 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.10e-08,9;UBERON:0002036,1.10e-08,9;UBERON:0002385,1.10e-08,9;UBERON:0000486,1.10e-08,9;UBERON:0007503,1.10e-08,9;UBERON:0001015,1.10e-08,9;UBERON:0002329,1.10e-08,9;UBERON:0003082,1.10e-08,9;UBERON:0003059,1.10e-08,9;UBERON:0007282,1.10e-08,9;UBERON:0004290,1.10e-08,9;UBERON:0009618,1.10e-08,9;UBERON:0000383,6.49e-08,10;UBERON:0007524,2.79e-07,11;UBERON:0003077,2.79e-07,11;UBERON:0007285,2.79e-07,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0.516493293766305,0.140788722151667,0,0,0,0.171200729931206,0.262261207256992,0,0,0,0,0,0,0,0,0.261199789138935,0,0,0,0,0.215471232685889,0,0,0,0,0,0,0,0,0,3.34825304589526,0.7813353445238,4.18818995179039,12.9410927366823,3.41522742479223,4.85510353031154,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162886959353576,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr13:51933176..51933183,+ | |||
}} |
Latest revision as of 02:33, 6 August 2015
Short description: | p@chr13:51933176..51933183, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr13:51933176..51933183, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 1.10e-08 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.10e-08 | 9 |
striated muscle tissue | 1.10e-08 | 9 |
muscle tissue | 1.10e-08 | 9 |
multilaminar epithelium | 1.10e-08 | 9 |
epithelial vesicle | 1.10e-08 | 9 |
musculature | 1.10e-08 | 9 |
somite | 1.10e-08 | 9 |
myotome | 1.10e-08 | 9 |
presomitic mesoderm | 1.10e-08 | 9 |
presumptive segmental plate | 1.10e-08 | 9 |
dermomyotome | 1.10e-08 | 9 |
trunk paraxial mesoderm | 1.10e-08 | 9 |
musculature of body | 6.49e-08 | 10 |
dense mesenchyme tissue | 2.79e-07 | 11 |
paraxial mesoderm | 2.79e-07 | 11 |
presumptive paraxial mesoderm | 2.79e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 6.68e-24 | 3 |
muscle cancer | 6.68e-24 | 3 |
organ system cancer | 1.61e-12 | 6 |